Company: STAA
Filing Date: 2025-02-26
Form Type: 8-K
Source: 0000950170-25-027880
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-02-26
Form: 8-K
Item: Item 7.01
Chunk 3
---
Item 7.01 Regulation FD Disclosure.

On February 26, 2025, the Company issued a press release (the “ Press Release”) announcing that the Company’s Board appointed Stephen C. Farrell to succeed Thomas G. Frinzi as President and Chief Executive Officer. The Press Release also announced that the Board elected Director Elizabeth Yeu, M. D., to serve as Board Chair. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

In connection with the Board’s appointment of Mr. Farrell as President and Chief Executive Officer, the Board also approved changes to the Company’s Board leadership. In addition to serving as the Lead Independent Director of the Company’s Board, Mr. Farrell also currently serves as Chair of the Audit Committee and a member of the Nominating and Governance Committee. Effective as of the Effective Date, Mr. Farrell will remain on the Board, but he will cease to serve as Lead Independent Director or serve on any Board Committee. Effective as of the Effective Date, the Board approved the separation of the offices of Chief Executive Officer and Board Chair, and the Board elected Dr. Yeu to serve as Board Chair. Further, the Board determined that Director Lilian Zhou, a current member of the Audit Committee, is “financially sophisticated” as that term is used in Nasdaq Rule 5605(c)(2)(A) and an “audit committee financial expert” as defined in Item 407(d)(5) of Regulation S-K, and appointed Ms. Zhou as Chair of the Audit Committee.

In addition, Effective as of the Effective Date, the Board approved a reduction in the size of the Board from seven (7) to six (6) members.

The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section. The information in Items 7.01 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

Item 9.01 Financial Statements and Exhibits.